Jole Ventriglia

Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis

Michele Orditura, Gennaro Galizia, Anna Diana et al. · ESMO Open · 2016 · 81 citations · Full text

Medicine, Biostatistics, Oncology +13

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Alberto Farolfi, Micaela Petrone, Emanuela Scarpi et al. · Targeted Oncology · 2018 · 60 citations

Medicine, Gynecology, Oncology +17

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro et al. · BMC Cancer · 2016 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13

Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

Maria Di Bartolomeo, Monica Niger, Giuseppe Tirino et al. · Targeted Oncology · 2018 · 37 citations

Medicine, Oncology, Pharmacology +12

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis

Jole Ventriglia, Angelica Petrillo, Maria Maddalena Laterza et al. · Gastroenterology Research and Practice · 2018 · 36 citations · Full text

Medicine, Oncology, Chemotherapy +14